Richardson, P. G., Hofmeister, C. C., Raje, N. S., Siegel, D. S., Lonial, S., Laubach, J., . . . Anderson, K. C. (2017). Pomalidomide, bortezomib and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma. Leukemia.
শিকাগো স্টাইলে সাইটেশনRichardson, P G., et al. "Pomalidomide, Bortezomib and Low-dose Dexamethasone in Lenalidomide-refractory and Proteasome Inhibitor-exposed Myeloma." Leukemia 2017.
এমএলএ সাইটেশনRichardson, P G., et al. "Pomalidomide, Bortezomib and Low-dose Dexamethasone in Lenalidomide-refractory and Proteasome Inhibitor-exposed Myeloma." Leukemia 2017.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.